Richard G Stefanacci, DO

Practical Research

High Utilization of CYP2D6 Substrate Prescriptions Among Long-Term Care Residents With Overactive Bladder

10/07/2022

Jason Yeaw , MPH;

Adam Carrera , PharmD;

Paul N. Mudd Jr., PharmD, MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

John R. Horn , PharmD;

Noelia Goti , BS;

Stacie Holland , PharmD;

Drishti Shah , PhD;

This study aims to describe the prevalence of CYP2D6 substrate use among LTC residents with OAB and among a subset of residents with OAB receiving mirabegron.

This study aims to describe the...

10/07/2022

Annals of Long-Term Care

Research Reports

Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study

05/18/2021

Drishti Shah , PhD;

Jason Yeaw , MPH;

Amy Kincaid , MA;

Paul N. Mudd Jr., PharmD, MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.

Richard Stefanacci, DO, and...

05/18/2021

Journal of Clinical Pathways